Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-17 4:00 pm Purchase | 2025-12-10 | 13G | Vor Biopharma Inc. VOR | Great Point Partners, LLC | 1,234,486 5.630% | 1,234,486 (New Position) | Filing History |
| 2025-11-14 3:40 pm Purchase | 2025-09-30 | 13G | Zura Bio Limited ZURA | Great Point Partners, LLC | 3,815,930 5.870% | 645,736 (+20.37%) | Filing History |
| 2025-11-14 3:18 pm Unchanged | 2025-09-30 | 13G | VistaGen Therapeutics, Inc. VTGN | Great Point Partners, LLC | 2,055,834 6.280% | 0 (Unchanged) | Filing History |
| 2025-11-14 3:02 pm Unchanged | 2025-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY | Great Point Partners, LLC | 796,558 4.510% | 0 (Unchanged) | Filing History |
| 2025-11-14 2:12 pm Purchase | 2025-09-30 | 13G | ProMIS Neurosciences, Inc. PMN | Great Point Partners, LLC | 238,895 9.990% | 105,514 (+79.11%) | Filing History |
| 2025-11-14 1:59 pm Sale | 2025-09-30 | 13G | Inventiva S.A. IVA | Great Point Partners, LLC | 8,636,151 6.060% | -1,940,676 (-18.35%) | Filing History |
| 2025-11-14 1:16 pm Unchanged | 2025-09-30 | 13G | Context Therapeutics Inc. CNTX | Great Point Partners, LLC | 4,683,711 5.220% | 0 (Unchanged) | Filing History |
| 2025-08-14 5:16 pm Purchase | 2025-06-30 | 13G | Unicycive Therapeutics, Inc. UNCY | Great Point Partners, LLC | 796,558 6.240% | 796,558 (New Position) | Filing History |
| 2025-08-14 5:15 pm Unchanged | 2025-06-30 | 13G | Outlook Therapeutics, Inc. OTLK | Great Point Partners, LLC | 2,220,000 4.990% | 0 (Unchanged) | Filing History |
| 2025-08-14 5:13 pm Unchanged | 2025-06-30 | 13G | VistaGen Therapeutics, Inc. VTGN | Great Point Partners, LLC | 2,055,834 6.590% | 0 (Unchanged) | Filing History |
| 2025-08-14 5:12 pm Unchanged | 2025-06-30 | 13G | ProMIS Neurosciences, Inc. PMN | Great Point Partners, LLC | 133,381 9.990% | 0 (Unchanged) | Filing History |
| 2025-08-14 5:11 pm Unchanged | 2025-06-30 | 13G | Context Therapeutics Inc. CNTX | Great Point Partners, LLC | 4,683,711 5.220% | 0 (Unchanged) | Filing History |
| 2025-06-20 12:47 pm Purchase | 2025-05-05 | 13G | Inventiva S.A. IVA | Great Point Partners, LLC | 10,576,827 7.420% | 10,576,827 (New Position) | Filing History |
| 2025-05-15 4:48 pm Unchanged | 2025-03-31 | 13G | VistaGen Therapeutics, Inc. VTGN | Great Point Partners, LLC | 2,055,834 6.650% | 0 (Unchanged) | Filing History |
| 2025-05-15 4:47 pm Unchanged | 2025-03-31 | 13G | Outlook Therapeutics, Inc. OTLK | Great Point Partners, LLC | 2,220,000 6.370% | 0 (Unchanged) | Filing History |
| 2025-05-15 4:45 pm Sale | 2025-03-31 | 13G | OptiNose, Inc. OPTN | Great Point Partners, LLC | 526,315 4.940% | -370,270 (-41.30%) | Filing History |
| 2025-05-15 4:44 pm Unchanged | 2025-03-31 | 13G | Context Therapeutics Inc. CNTX | Great Point Partners, LLC | 4,683,711 5.220% | 0 (Unchanged) | Filing History |
| 2025-05-14 4:11 pm Unchanged | 2025-05-08 | 13G | Zura Bio Limited ZURA | Great Point Partners, LLC | 3,170,194 5.120% | 0 (Unchanged) | Filing History |
| 2025-02-14 4:40 pm Sale | 2024-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | Great Point Partners, LLC | 2,055,834 6.880% | -674,075 (-24.69%) | Filing History |
| 2025-02-14 4:39 pm Purchase | 2024-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Great Point Partners, LLC | 1,147,317 9.990% | 195,073 (+20.49%) | Filing History |